Amendment: SEC Form SC 13G/A filed by Absci Corporation

11/12/24 9:50:12 AM ET

Biotechnology: Commercial Physical & Biological Resarch

Health Care

Get the next $ABSI alert in real time by email

SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.4 ABSCI CORP COMMON STOCK Cusip #00091E109 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #00091E109 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 12,726,985 Item 6: 0 Item 7: 12,727,759 Item 8: 0 Item 9: 12,727,759 Item 11: 11.208% Item 12: HC Cusip #00091E109 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 12,727,759 Item 8: 0 Item 9: 12,727,759 Item 11: 11.208% Item 12: IN Item 1(a). Name of Issuer: ABSCI CORP Item 1(b). Address of Issuer's Principal Executive Offices: 18105 SE MILL PLAIN BLVD VANCOUVER, WA 98683 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 00091E109 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 12,727,759 (b) Percent of Class: 11.208% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 12,727,759 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of ABSCI CORP. The interest of Fidelity Growth Company Commingled Pool, in the COMMON STOCK of ABSCI CORP, amounted to 5,787,534 shares or 5.096% of the total outstanding COMMON STOCK at September 30, 2024. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 8, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification Fidelity Management & Research Company LLC * IA Fidelity Management Trust Company * BK Strategic Advisers LLC IA * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on November 8, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of ABSCI CORP at September 30, 2024. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.

Get the next $ABSI alert in real time by email

Recent Analyst Ratings for

$ABSI

Date	Price Target	Rating	Analyst
5/28/2026	$9.00	Buy	BTIG Research
1/8/2026	$4.32	Overweight → Equal-Weight	Morgan Stanley
10/2/2025		Overweight	Analyst
7/3/2025	$7.00	Overweight	Morgan Stanley
1/22/2025	$9.00	Buy	Needham
10/2/2024	$10.00	Buy	Guggenheim
7/3/2024	$7.00	Overweight	Morgan Stanley
3/14/2024	$13.00	Sector Outperform	Scotiabank

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Absci Corporation

11/12/24 9:50:12 AM ET

$ABSI

Biotechnology: Commercial Physical & Biological Resarch

Health Care

Get the next $ABSI alert in real time by email

Recent Analyst Ratings for

$ABSI

Date	Price Target	Rating	Analyst
5/28/2026	$9.00	Buy	BTIG Research
1/8/2026	$4.32	Overweight → Equal-Weight	Morgan Stanley
10/2/2025		Overweight	Analyst
7/3/2025	$7.00	Overweight	Morgan Stanley
1/22/2025	$9.00	Buy	Needham
10/2/2024	$10.00	Buy	Guggenheim
7/3/2024	$7.00	Overweight	Morgan Stanley
3/14/2024	$13.00	Sector Outperform	Scotiabank

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Absci Corporation

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ABSI

Amendment: SEC Form SC 13G/A filed by Absci Corporation

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ABSI

$ABSI
Insider Trading

CFO / CBO Jonasson Zachariah covered exercise/tax liability with 8,319 shares, decreasing direct ownership by 2% to 491,464 units (SEC Form 4) to satisfy withholding tax

Director Pangalos Menelas N bought $200,748 worth of shares (37,453 units at $5.36), increasing direct ownership by 19% to 232,308 units (SEC Form 4)

Amendment: Chief Legal Officer Walker Shelby J. was granted 90,300 shares and covered exercise/tax liability with 9,825 shares, increasing direct ownership by 136% to 139,775 units (SEC Form 4)

$ABSI
Insider Purchases

Director Pangalos Menelas N bought $200,748 worth of shares (37,453 units at $5.36), increasing direct ownership by 19% to 232,308 units (SEC Form 4)

Chief Innovation Officer Busch Andreas bought $229,000 worth of shares (100,000 units at $2.29), increasing direct ownership by 31% to 421,446 units (SEC Form 4)

Director Pangalos Menelas N bought $205,760 worth of shares (75,095 units at $2.74), increasing direct ownership by 66% to 189,055 units (SEC Form 4)

$ABSI
Press Releases

Absci to Participate in Upcoming Investor Conferences

Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

$ABSI
Analyst Ratings

BTIG Research initiated coverage on Absci Corporation with a new price target

Absci Corporation downgraded by Morgan Stanley with a new price target

Analyst initiated coverage on Absci Corporation

$ABSI
SEC Filings

SEC Form 10-Q filed by Absci Corporation

Absci Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

SEC Form DEF 14A filed by Absci Corporation

$ABSI
Leadership Updates

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

$ABSI
Financials

Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results

Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

$ABSI
Large Ownership Changes

SEC Form SC 13G filed by Absci Corporation